Live from the NIH registry
Studies recruiting near Greenville right now
Top 25 of 373 recruiting studies, sorted by proximity — each links to its official registry page
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Advanced Solid Tumors
Phase 1, Phase 2
Interventional 83 participants sought
Prisma Health — Greenville, South Carolina (2.0 mi)
· Sponsor: Jiangsu HengRui Medicine Co., Ltd.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
AnMed Health Pulmonary and Sleep Medicine — Anderson, South Carolina (28.1 mi)
· Sponsor: Synairgen Research Ltd.
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
Prisma Health Greenville Memorial Hospital — Greenville, South Carolina (2.0 mi)
· Sponsor: Joseph Broderick, MD
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: SWOG Cancer Research Network
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Heart Failure
N/A
Interventional 1,200 participants sought
Prisma Health — Greenville, South Carolina (2.0 mi)
· Sponsor: Analog Device, Inc.
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Amyloidosis, Amyloid Cardiomyopathy
Phase 3
Interventional 587 participants sought
Prisma Health Cancer Institute — Greenville, South Carolina (2.0 mi)
· Sponsor: Eidos Therapeutics, a BridgeBio company
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
AnMed Health Medical Center — Anderson, South Carolina (28.1 mi)
· Sponsor: Duke University
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Bacterial Conjunctivitis
Phase 3
Interventional 400 participants sought
Baxis Site 33 — Greenville, South Carolina (2.0 mi)
· Sponsor: Baxis Pharmaceuticals, Inc.
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Actinic Keratosis
Phase 3
Interventional 160 participants sought
Palmetto Clinical Trial Services, LLC — Greenville, South Carolina (2.0 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Hematologic Malignancies
Phase 1, Phase 2
Interventional 160 participants sought
Bon Secours St. Francis Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: Sellas Life Sciences Group
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: SWOG Cancer Research Network
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 798 participants sought
Prisma Health-Upstate Cancer Institute — Greenville, South Carolina (2.0 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Supratentorial Hemorrhage
N/A
Observational 500 participants sought
Prisma Health - Upstate — Greenville, South Carolina (2.0 mi)
· Sponsor: Integra LifeSciences Corporation
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Systemic Lupus Erythematosus
Phase 3
Interventional 100 participants sought
Research Site — Greenville, South Carolina (2.0 mi)
· Sponsor: AstraZeneca
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Tribe Clinical Research at Parkside Pediatrics Five Forks — Simpsonville, South Carolina (9.2 mi)
· Sponsor: Pfizer
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Saint Francis Hospital — Greenville, South Carolina (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Pounce™ Thrombectomy System Retrospective Registry
Peripheral Arterial Disease, Acute Limb Ischemia
N/A
Observational 500 participants sought
Prisma Health Upstate — Greenville, South Carolina (2.0 mi)
· Sponsor: SurModics, Inc.
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 600 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: NRG Oncology
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Non-cystic Fibrosis Bronchiectasis
Phase 2
Interventional 284 participants sought
Velocity Clinical Research - Spartanburg - PPDS — Spartanburg, South Carolina (25.8 mi)
· Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
Advanced Solid Tumor
Phase 1, Phase 2
Interventional 387 participants sought
Prisma Health — Greenville, South Carolina (2.0 mi)
· Sponsor: OncoC4, Inc.
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group